NCT04398745 2025-05-23
DREAMM12
GlaxoSmithKline
Phase 1 Active not recruiting
Clinical Trials
8 trialsNCT02301117 2024-09-05
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Taiho Oncology, Inc.
Phase 1 Completed
NCT02571036 2023-12-13
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Deciphera Pharmaceuticals, LLC
Phase 1 Completed
NCT00854139 2020-03-04
Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
Massachusetts General Hospital
Phase 1 Completed
NCT01331941 2017-11-06
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
Amgen
Phase 1 Completed
NCT00418366 2015-08-19
A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT00062621 2013-02-05
Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00001835 2008-03-04
Oxaliplatin in Cancer Patients With Impaired Kidney Function
National Institutes of Health Clinical Center (CC)
Phase 1 Completed